February 27, 2013 / 1:26 PM / 5 years ago

Optimer Pharma exploring sale, shares jump

(Reuters) - Optimer Pharmaceuticals Inc OPTR.O said it was exploring a possible sale of the company among a full range of alternatives and that Chairman Henry McKinnell would act as chief executive for the duration of the review process.

Optimer shares were up 11.6 percent at $11.95 in premarket trading.

McKinnell will replace Pedro Lichtinger, who has been at the helm since 2010.

J.P. Morgan and Centerview Partners will advise Optimer on the process, with Sullivan & Cromwell LLP serving as legal adviser.

Reporting by Zeba Siddiqui in Bangalore; Editing by Joyjeet Das

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below